drugset / Trial / NCT01525719

Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma

NCT01525719 ↗

Phase 2 Unknown 40 enrolled Ratchavithi Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether everolimus is effective in the treatment of patients with advance cholangiocarcinoma.

Timeline

Start
2012-01
Primary completion
2013-12
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule 10 mg —

Indications